For Colon Cancer That No Longer Responds to Treatment, A New Drug Combination Offers Hope

Source: Pharmacy Times articles

Patients in a Phase 3 clinical trial who received sotorasib and panitumumab lived longer, suggesting the combination therapy could become the new standard of care.
Read More